BLOOD-FLOW IN BREAST-CANCER AND FIBROADENOMA ESTIMATED BY COLOR DOPPLER ULTRASONOGRAPHY

被引:37
作者
HOLCOMBE, C
PUGH, N
LYONS, K
DOUGLASJONES, A
MANSEL, RE
HORGAN, K
机构
[1] UNIV WALES COLL CARDIFF,COLL MED,DEPT SURG,CARDIFF,S GLAM,WALES
[2] UNIV WALES COLL CARDIFF,COLL MED,DEPT BIOENGN,CARDIFF,S GLAM,WALES
[3] UNIV WALES COLL CARDIFF,COLL MED,DEPT RADIOL,CARDIFF,S GLAM,WALES
[4] UNIV WALES COLL CARDIFF,COLL MED,DEPT PATHOL,CARDIFF,S GLAM,WALES
关键词
D O I
10.1002/bjs.1800820622
中图分类号
R61 [外科手术学];
学科分类号
摘要
Blood how was measured by colour Doppler ultrasonography in 33 fibroadenomas of size 5-31 mm and 28 malignant breast masses of 8-37mm visible on ultrasonography. There was detectable blood flow in 11 fibroadenomas and 21 cancers (P<0.01). The median peak systolic frequency was 1.0 (range 0.25-2.0)kHz in malignant tumours and 0.5 (range 0.2-1.25)kHz in fibroadenomas. Blood flow was not detected in the eight fibroadenomas of less than 13 mm but was present in five of seven cancers smaller than this. Five of six carcinomas with three or more detectable vessels were classified as grade III on histological examination, compared with two of 11 carcinomas with one or two vessels. Similarly, five of seven cancers with three or more detectable vessels had axillary lymph node metastases compared with two of 13 with only one or two vessels. Detectable blood flow in breast masses is more common in cancer than in fibroadenoma and is highly suggestive of malignancy if the mass is less than 13 mm in size. Malignant tumours with a larger number of vessels are more likely to be of high grade and to have associated axillary node metastases.
引用
收藏
页码:787 / 788
页数:2
相关论文
共 11 条
[1]   HISTOLOGICAL GRADING AND PROGNOSIS IN BREAST CANCER - A STUDY OF 1409 CASES OF WHICH 359 HAVE BEEN FOLLOWED FOR 15 YEARS [J].
BLOOM, HJG ;
RICHARDSON, WW .
BRITISH JOURNAL OF CANCER, 1957, 11 (03) :359-&
[2]   COLOR DOPPLER ULTRASONOGRAPHY STUDIES OF BENIGN AND MALIGNANT BREAST-LESIONS [J].
DIXON, JM ;
WALSH, J ;
PATERSON, D ;
CHETTY, U .
BRITISH JOURNAL OF SURGERY, 1992, 79 (03) :259-260
[3]  
FOLKMAN J, 1973, ANN SURG, V175, P409
[4]  
HERMANSEN C, 1987, CANCER, V60, P1866, DOI 10.1002/1097-0142(19871015)60:8<1866::AID-CNCR2820600832>3.0.CO
[5]  
2-Z
[6]   ANGIOGENESIS, ASSESSED BY PLATELET ENDOTHELIAL-CELL ADHESION MOLECULE ANTIBODIES, AS INDICATOR OF NODE METASTASES AND SURVIVAL IN BREAST-CANCER [J].
HORAK, ER ;
LEEK, R ;
KLENK, N ;
LEJEUNE, S ;
SMITH, K ;
STUART, N ;
GREENALL, M ;
STEPNIEWSKA, K ;
HARRIS, AL .
LANCET, 1992, 340 (8828) :1120-1124
[7]  
Konishi Y, 1992, MED REV, V42, P12
[8]  
SRIVASTAVA A, 1988, AM J PATHOL, V133, P419
[9]  
SRIVASTAVA A, 1986, EUR J SURG ONCOL, V12, P12
[10]  
SRIVASTAVA A, 1988, BRIT J SURG, V754, P851